mhurhangee/ep-ind-claims huggingface dataset:
A targeting-enhanced anticancer nanoparticle comprising non-covalently bound anticancer drugs, serum albumin as the nanoparticle base material, and porphyrin compounds as tumor-targeting moieties, wherein said targeting-enhanced nanoparticles are characterized by the presence of anticancer drugs in the nanoparticle core and the complex of serum albumin and porphyrin compounds in the outer nanoparticle shell.
A detection system for detecting a flying avian in an airspace comprising: a plurality of first imagers that are fixably positioned in each of a plurality of distinct alignment directions, each of the plurality of first imagers having a wide field of view for detecting a moving object; a plurality of second imagers each having a high zoom, wherein the second imagers form a stereo imager; a positioner operably connected to the second imagers for positioning the second imagers to image the moving object (230, 231, 232, 233) detected by the first imagers, wherein the positioner moves an alignment direction of the second imagers based on an output from the first imagers wherein said positioner comprises a motorized pan and tilt head connected to said second imagers for moving said alignment direction of said second imagers based on an output from said first imagers, wherein the positioner continuously aligns the second imagers; a processor operably connected to receive image data from the first imagers, the second imagers, or both to identify the moving object (230, 231, 232, 233) that is a flying avian based on said image data; wherein the plurality of first imagers are arranged in distinct alignment directions to provide full 360° and substantially complete hemispherical coverage of said airspace surrounding the detection system. a plurality of first imagers that are fixably positioned in each of a plurality of distinct alignment directions, each of the plurality of first imagers having a wide field of view for detecting a moving object; a plurality of second imagers each having a high zoom, wherein the second imagers form a stereo imager; a positioner operably connected to the second imagers for positioning the second imagers to image the moving object (230, 231, 232, 233) detected by the first imagers, wherein the positioner moves an alignment direction of the second imagers based on an output from the first imagers wherein said positioner comprises a motorized pan and tilt head connected to said second imagers for moving said alignment direction of said second imagers based on an output from said first imagers, wherein the positioner continuously aligns the second imagers; a processor operably connected to receive image data from the first imagers, the second imagers, or both to identify the moving object (230, 231, 232, 233) that is a flying avian based on said image data; wherein the plurality of first imagers are arranged in distinct alignment directions to provide full 360° and substantially complete hemispherical coverage of said airspace surrounding the detection system.
Pad intended to be fastened to a concave curved surface of an optical component so as to modify an optical power of said component, the pad comprising a Fresnel lens formed from a series of Fresnel regions placed inside one another parallel to a smooth face of said pad and exhibiting height jumps between two successive regions, said height jumps being measured in a direction (z) perpendicular to the smooth face at an optical centre of the pad, the pad being characterized in that it possesses: - a spherical general shape in addition to the height jumps between successive Fresnel regions, said spherical general shape having an average radius of curvature comprised between 135 mm and 53 mm, - and wherein the height jumps between successive Fresnel regions are located on a concave face of the pad, said height jumps between successive Fresnel regions exhibiting: - constant amplitudes inside a radius circle encircling the optical centre of the pad and of dimension defined depending on the power of the pad, - and variable amplitudes that increase in a peripheral portion of the pad, with distance from the optical centre to the exterior of said circle, - said radius circle having a value comprised between 5 mm and 25 mm for a power comprised between 1 dioptre and 10 dioptres, and a central first height-jump amplitude higher than or equal to 5 μm. - a spherical general shape in addition to the height jumps between successive Fresnel regions, said spherical general shape having an average radius of curvature comprised between 135 mm and 53 mm, - and wherein the height jumps between successive Fresnel regions are located on a concave face of the pad, said height jumps between successive Fresnel regions exhibiting: - constant amplitudes inside a radius circle encircling the optical centre of the pad and of dimension defined depending on the power of the pad, - and variable amplitudes that increase in a peripheral portion of the pad, with distance from the optical centre to the exterior of said circle, - said radius circle having a value comprised between 5 mm and 25 mm for a power comprised between 1 dioptre and 10 dioptres, and a central first height-jump amplitude higher than or equal to 5 μm. - constant amplitudes inside a radius circle encircling the optical centre of the pad and of dimension defined depending on the power of the pad, - and variable amplitudes that increase in a peripheral portion of the pad, with distance from the optical centre to the exterior of said circle, - said radius circle having a value comprised between 5 mm and 25 mm for a power comprised between 1 dioptre and 10 dioptres, and a central first height-jump amplitude higher than or equal to 5 μm.
A cell cultivating flask ( 2; 100;110;115) comprising: a cover including a top plate, a side wall and a resealable port; one or more intermediate tray(s) (30;92) for receiving cells and cell media, each intermediate tray (30;92) having a bottom plate, an underside, an upperside, a side wall, and a gap region formed between an interior upwardly angled lip (36;78) having an edge located on an interior portion of the bottom plate and an adjacent side wall portion of the bottom plate; and a base tray for receiving cells and cell media, the base tray including a bottom plate, an upperside and a side wall, wherein the bottom plate has a first substantially flat portion (24;86), a second substantially flat portion (26;84) located above the plane of the first flat portion (24;86) and connected to the first flat portion (24;86) by an interconnecting portion (28;81) that is at an angle so as to connect the first and second flat portions (24,26;86,84) together, wherein the intermediate tray(s) (30;92) is/are positioned between the cover and the base tray, and the gap region(s) of the intermediate tray(s) (30;92) and the second flat portion (26;84) of the base tray are in alignment with the port on the cover, resulting in the port, the intermediate tray(s) (30;92) and the base tray in fluid communication with one another providing direct access to cells and cell media when located on each of the intermediate and base trays (30;92,90). a cover including a top plate, a side wall and a resealable port; one or more intermediate tray(s) (30;92) for receiving cells and cell media, each intermediate tray (30;92) having a bottom plate, an underside, an upperside, a side wall, and a gap region formed between an interior upwardly angled lip (36;78) having an edge located on an interior portion of the bottom plate and an adjacent side wall portion of the bottom plate; and a base tray for receiving cells and cell media, the base tray including a bottom plate, an upperside and a side wall, wherein the bottom plate has a first substantially flat portion (24;86), a second substantially flat portion (26;84) located above the plane of the first flat portion (24;86) and connected to the first flat portion (24;86) by an interconnecting portion (28;81) that is at an angle so as to connect the first and second flat portions (24,26;86,84) together, wherein the intermediate tray(s) (30;92) is/are positioned between the cover and the base tray, and the gap region(s) of the intermediate tray(s) (30;92) and the second flat portion (26;84) of the base tray are in alignment with the port on the cover, resulting in the port, the intermediate tray(s) (30;92) and the base tray in fluid communication with one another providing direct access to cells and cell media when located on each of the intermediate and base trays (30;92,90).
Process for preparing a dry powder inhalation formulation containing tiotropium bromide and a lactose carrier, comprising the steps: a) splitting the lactose carrier into a first, a second and a third portion, b) mixing the first and the second portion of the lactose carrier and the drug by i) placing the first portion of the lactose carrier in a mixer to obtain a first layer, ii) placing the entire drug on top of the first lactose layer to obtain a second layer, iii) placing the second portion of the lactose carrier on top of the second layer to obtain a third layer, iv) blending the three-layered composition obtained in step (iii) to obtain a preblend, v) optionally sifting the preblend, c) mixing the preblend obtained in step (b) and the third portion of the lactose carrier to obtain the dry powder inhalation formulation, and d) optionally sifting the dry powder inhalation formulation. a) splitting the lactose carrier into a first, a second and a third portion, b) mixing the first and the second portion of the lactose carrier and the drug by i) placing the first portion of the lactose carrier in a mixer to obtain a first layer, ii) placing the entire drug on top of the first lactose layer to obtain a second layer, iii) placing the second portion of the lactose carrier on top of the second layer to obtain a third layer, iv) blending the three-layered composition obtained in step (iii) to obtain a preblend, v) optionally sifting the preblend, i) placing the first portion of the lactose carrier in a mixer to obtain a first layer, ii) placing the entire drug on top of the first lactose layer to obtain a second layer, iii) placing the second portion of the lactose carrier on top of the second layer to obtain a third layer, iv) blending the three-layered composition obtained in step (iii) to obtain a preblend, v) optionally sifting the preblend, c) mixing the preblend obtained in step (b) and the third portion of the lactose carrier to obtain the dry powder inhalation formulation, and d) optionally sifting the dry powder inhalation formulation.
A header for a harvester comprising a carrier frame (1, 2, 3), at least one first blade (5; 5r) displaceable in the carrier frame (1, 2, 3), a rotationally drivable drive train (9, 10, 11, 13, 14) rotatable in itself for the first blade (5; 5r) and an eccentric for converting a rotation of the drive train (9, 10, 11, 13, 14) into an oscillating movement of the first blade (5, 5r), characterised in that the drive train (9, 10, 11, 13, 14) includes at least one rotary play-bearing element which has a nonlinear return characteristic.
A method for protecting information in a computing system, comprising: creating, by an application residing in an un-trusted software environment in a local computing device of the computing system, data to be stored in a first segment of memory of a plurality of segments of memory in the local computing device; storing, by the application, the data in the first segment of memory; specifying, by the application residing in the un-trusted software environment, a data protection policy to govern access to the data stored in the first segment of memory; converting, by a tag policy conversion module executing in a trusted software environment of the local computing device, the data protection policy specified by the application to a separate, enforceable system-level data protection policy sealed by a trust coprocessor of the local computing device; tagging, by a memory protection module executing in the trusted software environment of the local computing device, the first segment of memory containing the stored data with a set of security tags of a plurality of security tags that define the separate, enforceable system-level data protection policy; and enforcing, by the memory protection module executing in the trusted software environment, the data protection policy specified by the application for the first segment of memory as a function of the set of security tags that define the separate, enforceable system-level data protection policy to protect the data stored in the first segment of memory. creating, by an application residing in an un-trusted software environment in a local computing device of the computing system, data to be stored in a first segment of memory of a plurality of segments of memory in the local computing device; storing, by the application, the data in the first segment of memory; specifying, by the application residing in the un-trusted software environment, a data protection policy to govern access to the data stored in the first segment of memory; converting, by a tag policy conversion module executing in a trusted software environment of the local computing device, the data protection policy specified by the application to a separate, enforceable system-level data protection policy sealed by a trust coprocessor of the local computing device; tagging, by a memory protection module executing in the trusted software environment of the local computing device, the first segment of memory containing the stored data with a set of security tags of a plurality of security tags that define the separate, enforceable system-level data protection policy; and enforcing, by the memory protection module executing in the trusted software environment, the data protection policy specified by the application for the first segment of memory as a function of the set of security tags that define the separate, enforceable system-level data protection policy to protect the data stored in the first segment of memory.
A method of monitoring usage of a mobile device, the method comprising: associating, with a processor, a first port number of a proxy server with an identifier of a mobile device (110, 130), and a first classification of a first Service Set Identifier, the first port number to be used by the mobile device (110, 130) when accessing a first wireless access point identified by the first Service Set Identifier; associating, with the processor, a second port number of the proxy server with the identifier of the mobile device (110, 130), and a second classification of a second Service Set Identifier, the second port number to be used by the mobile device when accessing a second wireless access point, the second port number being different from the first port number, the second wireless access point being different from the first wireless access point; generating a first instruction document identifying the first port number to be used when connected to the first wireless access point identified by the first Service Set Identifier; generating a second instruction document identifying the second port number to be used when connected to the first wireless access point identified by the second Service Set Identifier; and transmitting the first and the second instruction documents to the mobile device (110, 130). associating, with a processor, a first port number of a proxy server with an identifier of a mobile device (110, 130), and a first classification of a first Service Set Identifier, the first port number to be used by the mobile device (110, 130) when accessing a first wireless access point identified by the first Service Set Identifier; associating, with the processor, a second port number of the proxy server with the identifier of the mobile device (110, 130), and a second classification of a second Service Set Identifier, the second port number to be used by the mobile device when accessing a second wireless access point, the second port number being different from the first port number, the second wireless access point being different from the first wireless access point; generating a first instruction document identifying the first port number to be used when connected to the first wireless access point identified by the first Service Set Identifier; generating a second instruction document identifying the second port number to be used when connected to the first wireless access point identified by the second Service Set Identifier; and transmitting the first and the second instruction documents to the mobile device (110, 130). generating a first instruction document identifying the first port number to be used when connected to the first wireless access point identified by the first Service Set Identifier; generating a second instruction document identifying the second port number to be used when connected to the first wireless access point identified by the second Service Set Identifier; and transmitting the first and the second instruction documents to the mobile device (110, 130).
A rotor for a wind turbine, the rotor comprising a rotatable hub, at least one pair of blades arranged about said hub, and attaching means for attaching a portion of the blades to a portion of the hub, said attaching means comprising a number of bushings inside of which corresponding studs can be secured, at least some of the bushings being provided with at least one securing end that is adapted for providing the stud with a degree of rotation relative to the bushing into which it is secured, characterized in that the securing end of the bushing comprises an inner receiving member adapted for receiving a corresponding end of the stud, the receiving member being further adapted for being rotated in the interior of the bushing around an axis (y) substantially perpendicular to the longitudinal axis (x) of the bushing.
A solubilizate, containing and in particular consisting of curcumin in a content of 3 wt.% to 7 wt.%; and at least one further active substance, which comprises one or more substances selected from the group consisting of xanthohumol, plant extracts, in particular from the resin of the frankincense tree, licorice, cannabinoids, enzymes, in particular serrapeptase, coenzyme Q 10, α-lipoic acid, resveratrol; and at least one emulsifier having an HLB value in a range below 18, preferably between 13 and 18, namely polysorbate 80 or polysorbate 20 or a mixture of polysorbate 20 and polysorbate 80; wherein the polysorbate content is at least 70 wt.%, preferably in the range between 75 wt.% and 95 wt.%, most preferably in the range between 79 wt.% and 88 wt.%; for use in the treatment and/or prevention of diseases involving inflammation, cancer, Alzheimer's, Parkinson's, obesity, high cholesterol, elevated blood sugar, diabetes, metabolic syndrome, and/or autoimmune diseases, multiple sclerosis, for reducing visceral fat, for thermogenesis, for lowering cholesterol, in particular LDL cholesterol, and/or glucose in the blood and/or triglycerides in the blood, for improving macular pigment density, for reducing oxidative stress and/or for reducing the accumulation of fat in the hepatocytes, in particular as a pharmaceutical drug for treating and/or preventing fatty liver disease, Friedreich's ataxia, lysosomal diseases, in particular Tay-Sachs disease, arteriosclerosis, heart diseases, arthritis. curcumin in a content of 3 wt.% to 7 wt.%; and at least one further active substance, which comprises one or more substances selected from the group consisting of xanthohumol, plant extracts, in particular from the resin of the frankincense tree, licorice, cannabinoids, enzymes, in particular serrapeptase, coenzyme Q 10, α-lipoic acid, resveratrol; and at least one emulsifier having an HLB value in a range below 18, preferably between 13 and 18, namely polysorbate 80 or polysorbate 20 or a mixture of polysorbate 20 and polysorbate 80; wherein the polysorbate content is at least 70 wt.%, preferably in the range between 75 wt.% and 95 wt.%, most preferably in the range between 79 wt.% and 88 wt.%; for use in the treatment and/or prevention of diseases involving inflammation, cancer, Alzheimer's, Parkinson's, obesity, high cholesterol, elevated blood sugar, diabetes, metabolic syndrome, and/or autoimmune diseases, multiple sclerosis, for reducing visceral fat, for thermogenesis, for lowering cholesterol, in particular LDL cholesterol, and/or glucose in the blood and/or triglycerides in the blood, for improving macular pigment density, for reducing oxidative stress and/or for reducing the accumulation of fat in the hepatocytes, in particular as a pharmaceutical drug for treating and/or preventing fatty liver disease, Friedreich's ataxia, lysosomal diseases, in particular Tay-Sachs disease, arteriosclerosis, heart diseases, arthritis.
Embossed, deformable film with decorative surface, characterized in that the decorative surface has a coating which contains constituents as follows: a) an aqueous dispersion of a hydroxy-functional prepolymer, obtainable by reaction at least of the following components: i) a polycarbonate polyol having hydroxyl groups, ii) a polyester polyol having hydroxyl groups, iii) a polyisocyanate having isocyanate groups, iv) a compound which has at least two groups reactive towards isocyanate groups, and at least one group capable of forming anions, v) water, where components i) to iii) and the ratio of components i) to iii) are selected such that there is an excess of hydroxyl groups over the isocyanate groups, and b) nanoparticles having a number-average particle size, measured by means of laser correlation spectroscopy, of 5 to 100 nm, where the nanoparticles comprise or consist of silicon dioxide, titanium dioxide, aluminium oxide, aluminium dioxide, manganese dioxide, manganese oxide, zinc oxide, zinc dioxide, cerium oxide, cerium dioxide, iron oxide, iron dioxide and/or calcium carbonate, and c) a crosslinker which has at least two groups reactive towards hydroxyl groups. a) an aqueous dispersion of a hydroxy-functional prepolymer, obtainable by reaction at least of the following components: i) a polycarbonate polyol having hydroxyl groups, ii) a polyester polyol having hydroxyl groups, iii) a polyisocyanate having isocyanate groups, iv) a compound which has at least two groups reactive towards isocyanate groups, and at least one group capable of forming anions, v) water, where components i) to iii) and the ratio of components i) to iii) are selected such that there is an excess of hydroxyl groups over the isocyanate groups, and i) a polycarbonate polyol having hydroxyl groups, ii) a polyester polyol having hydroxyl groups, iii) a polyisocyanate having isocyanate groups, iv) a compound which has at least two groups reactive towards isocyanate groups, and at least one group capable of forming anions, v) water, b) nanoparticles having a number-average particle size, measured by means of laser correlation spectroscopy, of 5 to 100 nm, where the nanoparticles comprise or consist of silicon dioxide, titanium dioxide, aluminium oxide, aluminium dioxide, manganese dioxide, manganese oxide, zinc oxide, zinc dioxide, cerium oxide, cerium dioxide, iron oxide, iron dioxide and/or calcium carbonate, and c) a crosslinker which has at least two groups reactive towards hydroxyl groups.